Abstract
Interleukin 6 (IL-6) has been shown to inhibit the proliferation, but increase the motility, of wild-type ZR-75-1 human ductal breast carcinoma cells, a line of cells that resemble closely the malignant cells cultured from the ascitic effusion. IL-6-treated cells lose their epithelial character, become stellate or fusiform in shape, and migrate away from neighbors. In the wild-type ZR-75-1 cells, IL-6 causes cell-cell separation in preformed colonies as well as postmitotically. We have now investigated the action of IL-6 in clone B ZR-75-1 cells, which are morphologically distinct from wild-type ZR-75-1 cells. In the more polygonal rather than cuboidal clone B cells, IL-6 did not cause early inhibition of DNA synthesis and it caused little cell-cell separation in preformed colonies. However, IL-6 treatment markedly prolonged the interval between mitosis and readherence of daughter cells to their neighbors and the substratum. Supernatants from IL-6-treated cultures contained detached viable cells in increased numbers. Intermitotic intervals were prolonged in IL-6-treated cultures. IL-6-treated dividing breast carcinoma cells are characterized by an increased probability of separation from neighbors and the substratum.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Chen L., Mory Y., Zilberstein A., Revel M. Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon-beta 2. Proc Natl Acad Sci U S A. 1988 Nov;85(21):8037–8041. doi: 10.1073/pnas.85.21.8037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Drenckhahn D., Franz H. Identification of actin-, alpha-actinin-, and vinculin-containing plaques at the lateral membrane of epithelial cells. J Cell Biol. 1986 May;102(5):1843–1852. doi: 10.1083/jcb.102.5.1843. [DOI] [PMC free article] [PubMed] [Google Scholar]
- FARQUHAR M. G., PALADE G. E. Junctional complexes in various epithelia. J Cell Biol. 1963 May;17:375–412. doi: 10.1083/jcb.17.2.375. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Franke W. W., Cowin P., Schmelz M., Kapprell H. P. The desmosomal plaque and the cytoskeleton. Ciba Found Symp. 1987;125:26–48. doi: 10.1002/9780470513408.ch3. [DOI] [PubMed] [Google Scholar]
- Greenburg G., Hay E. D. Cytodifferentiation and tissue phenotype change during transformation of embryonic lens epithelium to mesenchyme-like cells in vitro. Dev Biol. 1986 Jun;115(2):363–379. doi: 10.1016/0012-1606(86)90256-3. [DOI] [PubMed] [Google Scholar]
- Hay E. D. Extracellular matrix, cell skeletons, and embryonic development. Am J Med Genet. 1989 Sep;34(1):14–29. doi: 10.1002/ajmg.1320340107. [DOI] [PubMed] [Google Scholar]
- Huff K. K., Kaufman D., Gabbay K. H., Spencer E. M., Lippman M. E., Dickson R. B. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res. 1986 Sep;46(9):4613–4619. [PubMed] [Google Scholar]
- Huff K. K., Lippman M. E. Hormonal control of plasminogen activator secretion in ZR-75-1 human breast cancer cells in culture. Endocrinology. 1984 May;114(5):1702–1710. doi: 10.1210/endo-114-5-1702. [DOI] [PubMed] [Google Scholar]
- Matsuura Y., Tatsumi M., Enami K., Morikawa S., Yamazaki S., Kohase M. Expression of IL-6/IFN-beta 2 in a baculovirus system and its biological function. Ann N Y Acad Sci. 1989;557:122–129. doi: 10.1111/j.1749-6632.1989.tb24005.x. [DOI] [PubMed] [Google Scholar]
- Revel M., Zilberstein A., Ruggieri R. M., Rubinstein M., Chen L. Autocrine interferons and interferon-beta 2. J Interferon Res. 1987 Oct;7(5):529–536. doi: 10.1089/jir.1987.7.529. [DOI] [PubMed] [Google Scholar]
- Tamm I., Cardinale I., Krueger J., Murphy J. S., May L. T., Sehgal P. B. Interleukin 6 decreases cell-cell association and increases motility of ductal breast carcinoma cells. J Exp Med. 1989 Nov 1;170(5):1649–1669. doi: 10.1084/jem.170.5.1649. [DOI] [PMC free article] [PubMed] [Google Scholar]